No Data
No Data
No Data
No Data
No Data
Compete for a new 10-billion-level racetrack! Global pharmaceutical giants grab the beach to lay out the nuclear medicine field
Morgan Stanley estimates that the radiopharmaceuticals market will grow from around $7 billion in 2022 to $39 billion by 2032.
Zhitong FinanceApr 12 09:35 ET
Perspective Therapeutics Is Maintained at Buy by B. Riley Securities
Perspective Therapeutics Is Maintained at Buy by B. Riley Securities
Dow JonesApr 9 13:57 ET
NYSE American New 52-Week Highs And Lows
New Highs 8 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Friedman Industries FRD 19.42 10,703 GA
Dow JonesApr 5 14:22 ET
Express News | Oppenheimer Reiterates Outperform on Perspective Therapeutics, Raises Price Target to $1.5
Moomoo 24/7Apr 1 09:27 ET
Perspective Therapeutics Inc (CATX) Reports Fiscal Year 2023 Financial Results
Yahoo FinanceMar 30 05:31 ET
Express News | Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
Moomoo 24/7Mar 28 13:49 ET
Kevin Lehmann : consistant steps pullback climb pullback climb and a rise trend
TrytosaveabitOP Kevin Lehmann: Yup! But it’s actually a pretty decent uptrend overall! Im thinking that tomorrow the uptrend should continue? Im actually looking for a decent up tomorrow? Now just have to see if it takes place! Hehehe! GL to ya!
Kevin Lehmann : note only a trial if fails stock can decline.
TrytosaveabitOP Kevin Lehmann: Disagree! I’ve seen a few fall on approval! Rare but happens! I know 2 in last 5 months that got a tiny move up but then fell all day long!
Kevin Lehmann : employees buying this stock stonybrook hosp
Kevin Lehmann : niece is too ,works there
loading...
TrytosaveabitOP : That should give them some operational capital! Hehehe
No Data
No Data
Kevin Lehmann : todays decline just a bigger spinng top will be bullish soon